![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Aging (Albany NY) |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer
effect of gemcitabine.
Aging (Albany NY). 2022;14.
PubMed
Abstract available
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal
Carcinoma.
Am J Clin Pathol. 2022;158:263-269.
PubMed
Abstract available
Correction to: Metastatic Rectal Linitis Plastica From Bladder Cancer.
Am J Gastroenterol. 2022;117:1336.
PubMed
Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical
Applications.
Anticancer Res. 2022;42:3767-3778.
PubMed
Abstract available
Mivebresib synergized with PZ703b, a novel Bcl-xl PROTAC degrader, induces
apoptosis in bladder cancer cells via the mitochondrial pathway.
Biochem Biophys Res Commun. 2022;623:120-126.
PubMed
Abstract available
Correction: BRD4 promotes the migration and invasion of bladder cancer cells
through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
Biochem Cell Biol. 2022;100:274-275.
PubMed
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive
bladder cancer.
BJU Int. 2022 Jul 31. doi: 10.1111/bju.15864.
PubMed
Abstract available
Identification of immune-related and autophagy-related genes for the prediction
of survival in bladder cancer.
BMC Genom Data. 2022;23:60.
PubMed
Abstract available
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder
urothelial carcinoma.
BMC Urol. 2022;22:120.
PubMed
Abstract available
Is it necessary to perform a retrosigmoid transposition of the left ureter in
Bricker Ileal Conduit surgery?
BMC Urol. 2022;22:116.
PubMed
Abstract available
Evaluating the role of Z-stack to improve the morphologic evaluation of urine
cytology whole slide images for high-grade urothelial carcinoma: Results and
review of a pilot study.
Cancer Cytopathol. 2022;130:630-639.
PubMed
Abstract available
Escherichia coli-specific CXCL13-producing TFH are associated with clinical
efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer.
Cancer Discov. 2022 Aug 5. pii: 707463. doi: 10.1158/2159-8290.CD-22-0201.
PubMed
Abstract available
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder
cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.
Cancer Gene Ther. 2022 Aug 1. pii: 10.1038/s41417-022-00506.
PubMed
Abstract available
Clinical evaluation of urine laminin-gamma2 monomer as a potent biomarker for
non-muscle invasive bladder cancer.
Cancer Med. 2022 Aug 4. doi: 10.1002/cam4.5087.
PubMed
Abstract available
Phototherapy with cancer-specific nanoporphyrin potentiates immunotherapy in
bladder cancer.
Clin Cancer Res. 2022 Aug 3. pii: 707432. doi: 10.1158/1078-0432.CCR-22-1362.
PubMed
Abstract available
Radical cystectomy and women's sexual health - can we do better?
Curr Opin Urol. 2022;32:545-553.
PubMed
Abstract available
RNA-based urinary assays for non-muscle invasive bladder cancer.
Curr Opin Urol. 2022;32:523-530.
PubMed
Abstract available
Molecular uropathology and cancer genetics for the urologist: key findings for
classification and diagnosis.
Curr Opin Urol. 2022;32:451-455.
PubMed
Abstract available
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial
carcinoma of the bladder.
Curr Opin Urol. 2022;32:561-566.
PubMed
Abstract available
Comparative performance of the different orthotopic urinary diversions.
Curr Opin Urol. 2022;32:554-560.
PubMed
Abstract available
Drug instillation in the management of urinary tract urothelial carcinoma.
Curr Opin Urol. 2022;32:531-535.
PubMed
Abstract available
The use of MRI in urothelial carcinoma.
Curr Opin Urol. 2022;32:536-544.
PubMed
Abstract available
Brief update of the new WHO classification for urothelial carcinoma.
Curr Opin Urol. 2022;32:511-516.
PubMed
Abstract available
Progression-free survival is an adequate endpoint for clinical trials of locally
advanced and metastatic urothelial carcinoma.
Curr Opin Urol. 2022;32:500-503.
PubMed
Abstract available
Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to
micropapillary and conventional high-grade urothelial carcinoma: Cytologic and
immuonohistochemical findings.
Diagn Cytopathol. 2022;50:E248-E254.
PubMed
Abstract available
THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular
Subtype, and Prognosis in Bladder Cancer.
Dis Markers. 2022;2022:7147279.
PubMed
Abstract available
Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial
Carcinoma.
Dis Markers. 2022;2022:2147494.
PubMed
Abstract available
Estimating National Exposures and Potential Bladder Cancer Cases Associated with
Chlorination DBPs in U.S. Drinking Water.
Environ Health Perspect. 2022;130:87002.
PubMed
Abstract available
Avoiding collider bias in Mendelian randomization when performing stratified
analyses.
Eur J Epidemiol. 2022;37:671-682.
PubMed
Abstract available
Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer
Discovery.
Eur Urol Focus. 2022 Jul 29. pii: S2405-4569(22)00166.
PubMed
Abstract available
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A
Single-center Prospective Randomized Noninferiority Trial.
Eur Urol Oncol. 2022;5:440-448.
PubMed
Abstract available
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper
Tract Urothelial Carcinoma.
Eur Urol Oncol. 2022;5:464-471.
PubMed
Abstract available
Intermediate-risk Non-muscle-invasive Bladder Cancer: Time To Tidy Up the Mess?
Eur Urol Oncol. 2022 Jul 27. pii: S2588-9311(22)00115.
PubMed
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
Eur Urol Oncol. 2022;5:449-450.
PubMed
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract
Urothelial Carcinoma.
Eur Urol Oncol. 2022;5:451-459.
PubMed
Abstract available
The Origin and Evolution of Bladder Cancer Stem Cells.
Front Cell Dev Biol. 2022;10:950241.
PubMed
Abstract available
Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for
Bladder Cancer by an Innovative Prediction Model.
Front Genet. 2022;13:918705.
PubMed
Abstract available
Safety and Efficacy of Programmed Cell Death 1 and Programmed Death Ligand-1
Inhibitors in the Treatment of Cancer: An Overview of Systematic Reviews.
Front Immunol. 2022;13:953761.
PubMed
Abstract available
Characterization of novel small non-coding RNAs and their modifications in
bladder cancer using an updated small RNA-seq workflow.
Front Mol Biosci. 2022;9:887686.
PubMed
Abstract available
CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by
Modulating HIF-1alpha Signaling Pathway.
Front Oncol. 2022;12:859707.
PubMed
Abstract available
Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than
Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for
Non-Muscle-Invasive Bladder Cancer.
Front Oncol. 2022;12:937638.
PubMed
Abstract available
Clinical potential of the Hippo-YAP pathway in bladder cancer.
Front Oncol. 2022;12:925278.
PubMed
Abstract available
Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A
Systematic Review and Meta-Analysis.
Front Oncol. 2022;12:907454.
PubMed
Abstract available
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel
Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Front Oncol. 2022;12:895413.
PubMed
Abstract available
The potential mechanism of Longsheyangquan Decoction on the treatment of bladder
cancer: Systemic network pharmacology and molecular docking.
Front Pharmacol. 2022;13:932039.
PubMed
Abstract available
Variation of Anxiety and Depression During a 3-Year Period as Well as Their Risk
Factors and Prognostic Value in Postoperative Bladder Cancer Patients.
Front Surg. 2022;9:893249.
PubMed
Abstract available
The causal association between smoking, alcohol consumption and risk of bladder
cancer: A univariable and multivariable Mendelian randomization study.
Int J Cancer. 2022 Jul 29. doi: 10.1002/ijc.34228.
PubMed
Abstract available
[6]-Gingerol induces Caspase-Dependent Apoptosis in Bladder Cancer cells via MAPK
and ROS Signaling.
Int J Med Sci. 2022;19:1093-1102.
PubMed
Abstract available
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial
Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for
Improved Risk Stratification.
Int J Mol Sci. 2022;23.
PubMed
Abstract available
Rosa hybrida Petal Extract Exhibits Antitumor Effects by Abrogating Tumor
Progression and Angiogenesis in Bladder Cancer Both In Vivo and In Vitro.
Integr Cancer Ther. 2022;21:15347354221114337.
PubMed
Abstract available
Non-invasive medical gas plasma augments bladder cancer cell toxicity in
preclinical models and patient-derived tumor tissues.
J Adv Res. 2022 Aug 2. pii: S2090-1232(22)00166.
PubMed
Abstract available
Autophagy blockade potentiates cancer-associated immunosuppression through
programmed death ligand-1 upregulation in bladder cancer.
J Cell Physiol. 2022 Jul 29. doi: 10.1002/jcp.30817.
PubMed
Abstract available
An insight into the diagnostic and prognostic value of HOX A13's expression in
non-muscle invasive bladder cancer.
J Clin Lab Anal. 2022 Jul 19:e24606. doi: 10.1002/jcla.24606.
PubMed
Abstract available
Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of
Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade.
J Immunol Res. 2022;2022:9962397.
PubMed
Abstract available
Preoperative White Blood Cell-Related Indicators Can Predict the Prognosis of
Patients with Transurethral Resection of Bladder Cancer.
J Inflamm Res. 2022;15:4139-4147.
PubMed
Abstract available
Metastatic melanoma concurrent to the urinary bladder and endometrium: Case
report.
J Med Imaging Radiat Oncol. 2022;66:643-646.
PubMed
Abstract available
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to
EZH2 and PI3K inhibitors.
JCI Insight. 2022 Jul 19. pii: 155899. doi: 10.1172/jci.insight.155899.
PubMed
Abstract available
Assessment of association between PD-L1 expression and clinicopathological
characteristics of Indonesian patients with high grade bladder urothelial
carcinoma.
Med J Malaysia. 2022;77.
PubMed
Abstract available
[Rectal metastasis of a resected urothelial bladder cancer].
Medicina (B Aires). 2022;82:609-612.
PubMed
Abstract available
A hypothesis-generating analysis on the role of TERT promoter mutation in
advanced urothelial carcinoma treated with immunotherapy.
Pathol Res Pract. 2022;236:153983.
PubMed
Abstract available
Tumor-infiltrating lymphocytes predict survival in >/= pT2 urothelial bladder
cancer.
Pathol Res Pract. 2022;237:154037.
PubMed
Abstract available
Bladder cancer with secondary muscle invasion - a prognostic dilemma.
Scand J Urol. 2022 Aug 3:1-2. doi: 10.1080/21681805.2022.2107068.
PubMed
Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients
with Urachal Cancer.
Urol Int. 2022;106:840-847.
PubMed
Abstract available
Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment
of Intraoperative Frozen Section.
Urol Int. 2022;106:816-824.
PubMed
Abstract available
Effectiveness and Safety of a Modified Technique of Transvesical Obturator Nerve
Block to Avoid Adductor Contractions during Transurethral Resection of Bladder
Tumors.
Urol Int. 2022;106:775-783.
PubMed
Abstract available
Reduction of Perioperative Antibiotic Prophylaxis in Open Radical Cystectomy with
Ileal Conduit Is Feasible: Results of a Prospective Clinical Trial.
Urol Int. 2022;106:825-831.
PubMed
Abstract available
Spinal Anesthesia Provides Longer Administration Time for Postoperative
Intravesical Chemotherapy after TUR-B Operation.
Urol Int. 2022;106:768-774.
PubMed
Abstract available
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk
stratification tables to predict outcomes in high-grade non-muscle-invasive
urothelial bladder cancer.
Urol Oncol. 2022 Jul 15. pii: S1078-1439(22)00227.
PubMed
Abstract available
[Disseminated tumour cells in bladder cancer].
Urologie. 2022;61:728-733.
PubMed
Abstract available
Relapses Rates and Patterns for Pathological T0 After Robot-Assisted Radical
Cystectomy: Results From the International Robotic Cystectomy Consortium.
Urology. 2022;166:177-181.
PubMed
Abstract available
Dysfunctional Voiding- Presentation of a Rare Case of Pediatric Non Muscle
Invasive Urothelial Bladder Carcinoma.
Urology. 2022;166:233-235.
PubMed
Abstract available
Enhanced Recovery After Surgery in the Urinary Diversion Population: Are
Protocols Applied Differently in the Benign Indication Population?
Urology. 2022;166:50-55.
PubMed
Abstract available
Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily
practice.
Virchows Arch. 2022;481:191-200.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by